Maximum Daily Dose of Zopiclone
The maximum recommended daily dose of zopiclone is 7.5 mg for most adults, with elderly patients (≥65 years) requiring a lower maximum of 3.75 mg daily.
Standard Dosing Guidelines
The optimal therapeutic dose of zopiclone for adult insomnia is 7.5 mg taken at bedtime 1, 2, 3. This dose has been established through multiple dose-ranging studies and demonstrates:
- Comparable efficacy to benzodiazepines (flurazepam 30 mg, nitrazepam 5 mg, temazepam 20 mg)
- Optimal balance between sleep improvement and tolerability
- Minimal next-day psychomotor impairment
Dose-Response Relationship
Studies examining doses from 3.75 mg to 15 mg show that:
- 3.75 mg and 7.5 mg provide the greatest incremental sleep improvement 3
- 11.25 mg and 15 mg increase side effects without proportional therapeutic benefit 3
- Side effects become clinically significant above 7.5 mg, making higher doses unfavorable for routine use 3
Special Population: Elderly Patients
For patients ≥65 years, start at 3.75 mg and do not exceed 7.5 mg 4. Geriatric patients demonstrate:
- Adequate hypnotic efficacy at 7.5 mg (comparable to flurazepam 15 mg)
- Good tolerability at this lower dose range
- The 7.5-10 mg range is recommended as the upper limit for elderly insomniacs 4
Critical Safety Considerations
Higher doses (>7.5 mg) in vulnerable populations carry significant risks:
- In dementia patients, doses ≥7.5 mg are associated with increased fracture risk (HR 1.67), hip fracture (HR 1.96), falls (HR 1.33), and ischemic stroke (HR 1.88) 5
- Three patients discontinued zopiclone 7.5 mg in an Alzheimer's trial due to intense daytime sedation and worsened agitation 6
- Avoid higher doses in elderly and dementia patients; non-pharmacological alternatives should be prioritized 5
Duration of Treatment
Zopiclone is indicated for short-term use only (maximum 4 weeks) 1, 2. Prescriptions beyond this duration increase risks of:
- Physical dependence (particularly in patients with substance abuse history)
- Tolerance development
- Withdrawal symptoms
Common Pitfalls to Avoid
- Do not exceed 7.5 mg in routine practice - the risk-benefit ratio becomes unfavorable
- Do not use 7.5 mg as a starting dose in elderly patients - begin at 3.75 mg
- Do not prescribe for chronic use - limit to 4 weeks maximum
- Avoid in patients with dementia when possible - consider non-pharmacological interventions first 5
The most common adverse effect is bitter taste (reported by <10% of patients), which is generally well-tolerated 1.